Who owns TAYSHA GENE THERAPIES INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Taysha Gene Therapies with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Taysha Gene Therapies stock

Who bought or sold TAYSHA GENE THERAPIES INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
RA Capital Management 19M $33M 0% Dec 2023
 View chart
VR Adviser 10M $18M -28% Dec 2023
 View chart
Vanguard Group 6.2M $11M 16% Dec 2023
 View chart
venBio Select Advisor 4.4M $7.7M 11% Dec 2023
 View chart
Baker Bros. Advisors 4.0M $7.1M 60% Dec 2023
 View chart
Artal Group 3.7M $6.5M 0% Dec 2023
 View chart
Millennium Management 3.4M $6.1M 6761% Dec 2023
 View chart
Point72 Asset Management 2.7M $4.8M 187% Dec 2023
 View chart
Citadel Advisors 2.3M $4.1M 3643% Dec 2023
 View chart
T. Rowe Price Associates 1.2M $2.2M -2% Dec 2023
 View chart
Schonfeld Strategic Advisors 1.1M $2.0M 55% Dec 2023
 View chart
Exome Asset Management 693k $1.2M 100% Dec 2023
 View chart
Alphabet 641k $1.1M 0% Dec 2023
 View chart
Quantum Private Wealth 640k $1.1M 11% Dec 2023
 View chart
Palo Alto Investors 530k $938k 100% Dec 2023
 View chart
Citigroup 311k $550k 11% Dec 2023
 View chart
Monaco Asset Management SAM 295k $522k 100% Dec 2023
 View chart
Kovitz Investment Group Partners 278k $492k 1011% Dec 2023
 View chart
ADAR1 Capital Management 209k $370k 100% Dec 2023
 View chart
Polar Securities 187k $331k 100% Dec 2023
 View chart
TD Asset Management 176k $311k 0% Dec 2023
 View chart
Two Sigma Investments 137k $242k 100% Dec 2023
 View chart
Chicago Partners Investment 135k $198k 21% Dec 2023
 View chart
Bank of America Corporation 122k $217k 220% Dec 2023
 View chart
Goldman Sachs Group 84k $148k 100% Dec 2023
 View chart
Squarepoint Ops 64k $112k 122% Dec 2023
 View chart
Bank of New York Mellon 58k $103k 123% Dec 2023
 View chart
Cubist Systematic Strategies 48k $86k 100% Dec 2023
 View chart
Dynamic Advisors Solutions 45k $129k 0% Mar 2024
 View chart
Williams & Novak 45k $80k 0% Mar 2024
 View chart
Redwood Wealth Management Group 43k $75k 12% Dec 2023
 View chart
Jane Street 42k $75k 100% Dec 2023
 View chart
Jpmorgan Chase & Co 37k $65k 26531% Dec 2023
 View chart
Connor, Clark & Lunn Investment Management 35k $63k 100% Dec 2023
 View chart
Graham Capital Management 29k $50k 100% Dec 2023
 View chart
Commonwealth Equity Services 27k $47k -1% Dec 2023
 View chart
Virtu Financial 26k $46k 100% Dec 2023
 View chart
Cannon Global Investment Management 24k $70k 100% Mar 2024
 View chart
China Universal Asset Management 22k $38k 100% Dec 2023
 View chart
Lee Financial 20k $35k 0% Dec 2023
 View chart
Dynamic Technology Lab Private 17k $31k 100% Dec 2023
 View chart
Two Sigma Securities 17k $30k -38% Dec 2023
 View chart
Charles Schwab Investment Management 16k $29k 0% Dec 2023
 View chart
Victory Capital Management 16k $28k 100% Dec 2023
 View chart
Howard Capital Management 14k $25k 100% Dec 2023
 View chart
Darren Munn 11k $20k 100% Dec 2023
 View chart
Royal Capital Wealth Management 11k $19k 100% Dec 2023
 View chart
Capital Investment Advisors 10k $29k 0% Mar 2024
 View chart
Lazard Asset Management 8.8k $0 100% Dec 2023
 View chart
Quarry 8.0k $14k 100% Dec 2023
 View chart
Wells Fargo & Company 7.4k $13k 14% Dec 2023
 View chart
UBS Group 3.9k $7.0k 617% Dec 2023
 View chart
Hanson McClain Advisors 1.0k $1.8k 0% Dec 2023
 View chart
Morton Brown Family Wealth 260.00 $459.992000 100% Dec 2023
 View chart
Advisor Group Holdings 134.00 $237.997400 0% Dec 2023
 View chart
Capital Advisors 79.00 $0 0% Mar 2024
 View chart
Signature 50.00 $89.000000 100% Dec 2023
 View chart

Who sold out of Taysha Gene Therapies?

Fund or Company Name Date Sold Shares Held Valued At
Kynam Capital Management Sep 2023 3.3M $10M
Octagon Capital Advisors Sep 2023 2.8M $8.8M
Franklin Resources Sep 2023 811k $2.6M
Simplex Trading Sep 2023 15k $46k